Brief: Corum Says Arrotex Pharmaceuticals To Become Strategic Shareholder
Nov 6 (Reuters) - Corum Group Ltd COO.AX :
* AGREEMENT WITH ARROTEX PHARMACEUTICALS TO BECOME STRATEGIC
SHAREHOLDER IN CO
* PLACEMENT AGREEMENT FOR ISSUE OF 60 MILLION NEW SHARES OF
CO AT
5.5 CENTS/SHARE TO RAISE $3.3 MILLION
Source text for Eikon: ID:nASXbRsJVV
Further company coverage: COO.AX
((Reuters.Briefs@thomsonreuters.com))
Recent news on Pharmx Technologies
See all newsBrief: Pharmx Technologies Posts FY26 Total Revenue Of A$7.7 Million
Brief: Pharmx Technologies Reports Agreement Of First Work Item Under Sigma Alliance
Australia's Pharmx Technologies rises on gross transaction value growth
Brief: Pharmx Technologies Enters Multi-Year Strategic Alliance With Sigma
Brief: Pharmx Technologies Seeks Trading Halt